The positive correlation of LASP1 expression with the development of NPC indicated that the detection of LASP1 expression in resected NPC tissues could not only serve as a postoperative prognostic biomarker for NPC patients but also imply a potential therapeutic target for preventing NPC progression. The gene discussed is LASP1; the disease is nasopharyngeal carcinoma.